EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Following my coverage on Zillow Group (NASDAQ: ZG ) in August’24, which I recommended a buy rating due to my view that ZG is best positioned to capitalize on the improving macro environment, this post is to provide anI take a fundamentals-based approach to value investing.I disagree with the common misconception held by many investors that low multiple stocks must be cheap. I look for companies that offer the best long-term durability at the most affordable prices. Consequently, I have a propensity to be dr ...

Alaska Air Group, Inc. ALK shares are trading higher on Thursday.Goldman Sachs analyst Catherine O’Brien indicates that there could be potential upside to the company’s 2027 EPS target, taking into account factors such as the recently announced $1 billion share repurchase authorization, improvements in the industry environment, the full recovery of Hawaiian’s revenue, the economic benefits from a new joint co-brand credit card deal, and potential solutions to mitigate the current volatility in West Coast je ...

Guests can have gifts delivered on Christmas Eve with same-day delivery for orders placed by 3 p.m. Drive Up and Order Pickup orders placed by 6 p.m. will also be available the same day Most Target stores are open until midnight through Dec. 23 and until 8 p.m. on Christmas Eve. All Target stores will be closed on Christmas Day Shoppers can save with Target's Holiday Countdown Sale Dec. 12-14, and exclusive deals of up to 40% off through Dec. 24 with the retailer's free-to-join Target Circle program MINNE ...

Boston, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Target Test Prep (TTP), a recognized leader in standardized test preparation, has been named the top Executive Assessment (EA) prep course for 2024 by Consumer365. The company’s focused, data-driven approach to EA preparation has earned it high marks for its clarity, flexibility, and comprehensive content, making it the preferred choice for working professionals aiming to advance their business education. Best EA Test Prep: Target Test Prep - applies a combination ...

Altamira Gold Defines New, High-Ranking Gold Target (Guillermo) with Surface Grab Sample of 39g/t Gold, within the Cajueiro DistrictDecember 11, 2024 7:30 AM EST | Source: Altamira Gold Corp.Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (OTC Pink: EQTRF) ("Altamira" or the "Company"), is pleased to announce the discovery of a new gold target, identified as part of the ongoing exploration program within the Cajueiro district whi ...

公司核心观点 - SeaStar Medical Holding Corporation 估计其专利的 Selective Cytopheretic Device (SCD) 在美国五个临床适应症的总可寻址市场为 250 亿至 330 亿美元[1] 市场规模与临床试验成本 - 公司估计五个临床适应症的美国总可寻址市场和临床试验成本如下： - 成人急性肾损伤 (AKI)：年美国患者人口 210,000，总可寻址市场 47 亿至 63 亿美元，临床试验成本 1.54 亿美元[2] - 无 LVAD 的心肾综合征：年美国患者人口 580,000，总可寻址市场 131 亿至 174 亿美元，临床试验成本 500 万美元[2] - 成人急性呼吸窘迫综合征 (ARDS)：年美国患者人口 200,000，总可寻址市场 45 亿至 60 亿美元，临床试验成本 1,000 万美元[2] - 成人肝肾综合征：年美国患者人口 50,000，总可寻址市场 11 亿至 15 亿美元，临床试验成本 400 万美元[2] - 有 LVAD 的心肾综合征：年美国患者人口 60,000，总可寻址市场 14 亿至 18 亿美元，临床试验成本 400 万美元[2] 产品与技术 - Selective Cytopheretic Device (SCD) 是一种专利的细胞定向体外设备，采用免疫调节技术，在连续肾脏替代疗法 (CRRT) 期间选择性靶向促炎中性粒细胞和单核细胞，减少超炎症环境，包括细胞因子风暴[6] - SCD-Pediatric 设备 QUELIMMUNE 已获得 FDA 批准，用于治疗体重 10 公斤或以上、正在接受 RRT 治疗的 AKI 和脓毒症或脓毒症状态的危重儿童[7] 临床试验进展 - NEUTRALIZE-AKI 临床试验预计将招募多达 200 名成人 AKI 患者，目前已有 69 名受试者入组[8] - 试验的主要终点是 90 天死亡率或接受 SCD 治疗加 CRRT 标准护理的患者与仅接受 CRRT 标准护理的对照组之间的透析依赖性[8] 监管与商业化 - SCD 在三个适应症中获得了 FDA 突破性设备指定 (BDD)，包括成人 AKI、肝肾综合征和有 LVAD 的心肾综合征[2] - 公司最近向 FDA 提交了慢性透析的临床试验方案以供审查[2] - QUELIMMUNE 于 2024 年 2 月获得 FDA 批准，用于治疗 AKI 和脓毒症的危重儿童[7]

Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the FcRn inhibitor, historical and Competitive Landscape as well as the FcRn inhibitors' market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.The report provides current treatment practices, emerging dr ...

Bonterra Announces Additional Assay Results from Moss Target and Restart of Drilling by Gold Fields at Phoenix JVDecember 11, 2024 6:00 AM EST | Source: Bonterra Resources Inc.Val-d'Or, Quebec--(Newsfile Corp. - December 11, 2024) - Bonterra Resources Inc. (TSXV: BTR) (OTCQX: BONXF) (FSE: 9BR2) ("Bonterra" or the "Company") is pleased to announce additional assay results from the Moss target and the restart of drilling by a 100% indirect subsidiary of Gold Fields Ltd ("Gold Fields" or the "Ope ...

If you want full access to all our reports, data and investing ideas, join The Aerospace Forum , the #1 aerospace, defense and airline investment research service on Seeking Alpha, with access to evoX Data Analytics, our in-house developed data analytics platform.Airbus ( OTCPK:EADSF ) ( OTCPK:EADSY ) and Boeing ( BA ) have had significant challenges in raising production rates on their commercial airplane programs. While different in nature, the result is the same: Airlines are suffering fromDhierin runs t ...